NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences, Inc. (OTCQB: SVFC.PK) (PINKSHEETS: SVFC.PK) announces Ray Dirks Research Article published on www.CPreports.com .
In an update to Ray Dirks November 2011 report on Intellicell BioSciences Inc., Mr. Dirks discusses the impact of IntelliCell’s recent equity raise. In addition, he calls IntelliCell’s Stromal Vascular Fraction Celluar Therapy a game changer in the treatment of Orthopedic and sport injury inflammatory conditions.
In an update to Ray Dirks November 2011 report on Intellicell BioSciences Inc., Mr. Dirks discusses the impact of IntelliCell’s recent equity raise. In addition, he calls IntelliCell’s Stromal Vascular Fraction Celluar Therapy a game changer in the treatment of Orthopedic and sport injury inflammatory conditions.
